Dyadic International Inc (DYAI)
1.52
+0.03
(+2.01%)
USD |
NASDAQ |
Apr 24, 16:00
1.52
0.00 (0.00%)
After-Hours: 20:00
Dyadic International Cash from Investing (TTM): 7.450M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 7.450M |
September 30, 2023 | 8.034M |
June 30, 2023 | 3.196M |
March 31, 2023 | 0.9188M |
December 31, 2022 | -2.369M |
September 30, 2022 | 1.513M |
June 30, 2022 | 6.828M |
March 31, 2022 | 10.48M |
December 31, 2021 | 5.222M |
September 30, 2021 | 0.7598M |
June 30, 2021 | 8.210M |
March 31, 2021 | 14.64M |
December 31, 2020 | 22.12M |
September 30, 2020 | 23.42M |
June 30, 2020 | 13.23M |
March 31, 2020 | 6.399M |
December 31, 2019 | 7.708M |
September 30, 2019 | 8.277M |
June 30, 2019 | 8.247M |
March 31, 2019 | 6.458M |
December 31, 2018 | 3.328M |
September 30, 2018 | 3.298M |
June 30, 2018 | -2.673M |
March 31, 2018 | -8.462M |
December 31, 2017 | -0.8121M |
Date | Value |
---|---|
September 30, 2017 | 3.455M |
June 30, 2017 | 7.073M |
March 31, 2017 | -35.02M |
December 31, 2016 | -42.56M |
September 30, 2016 | 18.27M |
June 30, 2016 | 19.34M |
March 31, 2016 | 66.79M |
December 31, 2015 | 66.83M |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
March 31, 2014 | -0.3883M |
December 31, 2013 | -0.4141M |
September 30, 2013 | -0.25M |
June 30, 2013 | -0.17M |
March 31, 2013 | -0.1594M |
September 30, 2012 | -0.125M |
June 30, 2012 | -0.1533M |
March 31, 2012 | -0.6013M |
December 31, 2006 | -0.8596M |
September 30, 2006 | -0.8952M |
June 30, 2006 | -0.991M |
March 31, 2006 | -0.7027M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-2.369M
Minimum
Dec 2022
23.42M
Maximum
Sep 2020
8.121M
Average
7.708M
Median
Dec 2019
Cash from Investing (TTM) Benchmarks
AIM ImmunoTech Inc | -0.832M |
Perspective Therapeutics Inc | 24.37M |
Protalix BioTherapeutics Inc | -16.71M |
Electromed Inc | -1.219M |
Armata Pharmaceuticals Inc | -8.134M |